Current Clinical Trials
Department: Oncology
Diagnosis: Genito-urinary - Miscellaneous
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: CALGB
Indentifier #: NCT00942331
Title: CALGB-90601 A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, And Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT01470612
Title: A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Georgetson M.D., Michael
Sub-Investigator(s):
Sponsor: Coronado
Indentifier #: NCT01576471
Title: Phase II study to evaluate the efficacy and safety of 12 weeks of treatment with two different doses of oral CNDO 201 Trichuris suis ova suspension (TSO) as compared to placebo, followed by a 12 week open-label treatment period with TSO, in patients with moderate to severe active Crohn's disease.
Department: Oncology
Diagnosis: Cancer Control
Principal Investigator: Srivatana M.D., Panit
Sub-Investigator(s):
Sponsor: Alexion
Indentifier #: NCT01374360
Title: Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry
Department: Oncology
Diagnosis: Hematology- Lymphoma
Principal Investigator: Srivatana M.D., Panit
Sub-Investigator(s):
Sponsor: Allos
Indentifier #: NCT01110733
Title: COMPLETE Registry, Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma